by PMH Genesis Cell | Dec 10, 2020 | News & Resources
Abstract As the most common form of joint disorder, osteoarthritis (OA) imposes a tremen- dous burden on health care systems worldwide. Without effective cure, OA represents a unique opportunity for innovation in therapeutic development. In contrast to traditional...
by PMH Genesis Cell | Dec 10, 2020 | News & Resources
Abstract Premature ovarian failure is a relatively common condition that affects 1–3% of adult women. Premature ovarian failure occurs when there is loss of ovarian function in women younger than 40 years of age. The causes are mostly iatrogenic or idiopathic....
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Mesenchymal stem cells (MSCs) are multipotent non-haematopoietic progenitor cells that are being explored as a promising new treatment fortissue regeneration. Although their immunomodulatory properties are not yet completely understood, their low immunogenic...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract The World Health Organization estimates that diabetes will be the fourth most prevalent disease by 2050. Developing a new therapy for diabetes is a challenge for researchers and clinicians in field. Many medications are being used for treatment of diabetes...
by PMH Genesis Cell | Dec 1, 2020 | News & Resources
Abstract Degenerative joint disease presents inherent complexity with treatment because of itsprogressive nature, and as a result, there are limited options for definitive treatment.Mesenchymal stem cells (MSCs) have been implicated in treatment of such...
